27/08/2007 (Agence Europe) - Further to the recall of the product from the EU market in June 2007, the European Commission suspended, on 7 August, the marketing authorisation for Roche's antiretroviral medicinal product, Viracept - an antiretroviral medicine used in combination with other antiviral medicines to treat adults, adolescents and children over 3 years of age who are infected with the human immunodeficiency virus, HIV-1. Suspension follows the contamination of certain batches of...